Drug companies should cut prices for developing countries, says G8 report.
作者信息
Walgate Robert
出版信息
Bull World Health Organ. 2003;81(1):72-3. Epub 2003 Mar 11.
Abstract
摘要
相似文献
1
Drug companies should cut prices for developing countries, says G8 report.八国集团报告称，制药公司应为发展中国家降低药价。
Bull World Health Organ. 2003;81(1):72-3. Epub 2003 Mar 11.
2
Reprivatizing pharmaceutical supplies in Africa.非洲药品供应的重新私有化
J Public Health Policy. 2001;22(2):198-225.
3
TRIPS, pharmaceuticals, developing countries, and the Doha "solution".《与贸易有关的知识产权协定》、药品、发展中国家与多哈“解决方案”
Chic J Int Law. 2002 Spring;3(1):47-68.
4
EU launches measures to stop diversion of cut-price drugs.欧盟出台措施以阻止低价药品的转售。
Bull World Health Organ. 2003;81(7):549. Epub 2003 Sep 3.
5
[Access of developing countries to essential drugs: a process of equity].[发展中国家获取基本药物：一个公平的进程]
Bull Acad Natl Med. 2001;185(7):1255-66; discussion 1266-9.
6
Innovation and the WHO's essential medicines list: giving credit where credit is due.创新与世界卫生组织基本药物清单：该归功之处归功于人。
Res Social Adm Pharm. 2007 Mar;3(1):137-44. doi: 10.1016/j.sapharm.2006.05.006.
7
Access to and price of medicines globally.全球药品的可及性与价格
Tidsskr Nor Laegeforen. 2011 Oct 18;131(20):2019-21. doi: 10.4045/tidsskr.11.0744.
8
Companies reduce prices for HIV drugs in developing countries.制药公司降低了在发展中国家销售的抗艾滋病药物的价格。
Bull World Health Organ. 2000;78(6):862.
9
TRIPS, pharmaceutical patents, and access to essential medicines: a long way from Seattle to Doha.《与贸易有关的知识产权协定》、药品专利与基本药物的获取：从西雅图到多哈的漫长之路
Chic J Int Law. 2002 Spring;3(1):27-46.
10
Rational drug use. Part I: The role of national drug policies.合理用药。第一部分：国家药物政策的作用。
Cent Afr J Med. 2000 Aug;46(8):229-32.
Zotero 插件